Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

The relationship to survival after first recurrence of oestrogen receptor (ER), nodal status and TNM stage at diagnosis, and treatment for advanced disease was studied in 457 females whose primary breast cancer was diagnosed in 1975 to 1981. Receptor concentration was the most important predictor of post-recurrence survival, with some additional information conveyed by nodal status. ER predicted survival after recurrence independently of nodal status, clinical stage or mode of therapy. Response to endocrine therapy is only a facet of the generally favourable prognosis of ER positive patients, rather than the sole explanation.

• Publication year

  1987

• Venue

  British Journal of Cancer

• Publication date

  1987-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bjc.1987.298PMID 3435707PMCID 2002407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of estrogen and progesterone receptors and histological grade in human primary breast cancer.

  2009cited by this paper
• Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

  2005cited by this paper
• Prognostic value of estrogen and progesterone receptors in primary breast cancer

  2005cited by this paper
• Estrogen receptor status as a prognostic indicator for stage I breast cancer patients

  2005cited by this paper
• The clinical course of bone metastases from breast cancer.

  1987cited by this paper
• Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

  1987cited by this paper
• The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis.

  1986cited by this paper
• Survival patterns in hormone treated advanced breast cancer

  1986cited by this paper
• Survival of patients with relapsing breast cancer: analysis of 302 patients.

  1986cited by this paper
• A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers

  1986cited by this paper
• Role of steroid hormone receptors as prognostic factors in primary breast cancer.

  1986cited by this paper
• The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.

  1985cited by this paper
• Mechanisms in endocrine therapy of bone metastases.

  1985cited by this paper
• Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.

  1985cited by this paper
• Recent concepts of cancer metastasis and their implications for therapy.

  1984cited by this paper
• Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.

  1984cited by this paper
• Cancer surgery: a commentary.

  1984cited by this paper
• Steroid-hormone receptors and survival after first relapse in breast cancer.

  1984cited by this paper
• BMDP statistical software

  1983cited by this paper
• Influence and significance of certain prognostic factors on survival in breast cancer.

  1982cited by this paper
• Oestrogen-receptor status and sites of metastasis in breast cancer.

  1981cited by this paper
• Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients

  1981cited by this paper
• Estrogen receptor: A prognostic factor in breast cancer

  1981cited by this paper
• Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.

  1980cited by this paper
• Quality control of estrogen receptor assays.

  1980cited by this paper
• Relationship between proliferative activity and estrogen receptors in breast cancer

  1979cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam.

  1973cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Keeping abreast about Ashwagandha in breast cancer.

  2020cites this paper
• Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.

  2017cites this paper
• Improved survival in metastatic breast cancer 1985-2016.

  2017cites this paper
• Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data

  2014cites this paper
• Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.

  2014cites this paper
• New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up

  2008cites this paper
• Active and passive cigarette smoke and breast cancer survival.

  2007cites this paper
• Quality Indicators for the Care of Breast Cancer in Vulnerable Elders

  2007cites this paper
• Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.

  2006cites this paper
• Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

  2006cites this paper
• Hormone receptor status and survival in a population‐based cohort of patients with breast carcinoma

  2005cites this paper
• NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis

  2004cites this paper
• The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse.

  2004cites this paper
• NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.

  2004cites this paper
• Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy

  2004cites this paper
• Significance o f A xillary L ymph N ode M etastasis in P rimary B reast C ancer

  1999cites this paper
• Significance of axillary lymph node metastasis in primary breast cancer.

  1999cites this paper
• Estradiol receptors and metastasis in human breast cancer.

  1996cites this paper
• A multivariate analysis of prognostic factors including tumor response after endocrine therapy in advanced breast cancer patients.

  1995cites this paper
• Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.

  1994cites this paper
• Relationship between variant forms of estrogen receptor RNA and an apoptosis‐related RNA, TRPM‐2, with survival in patients with breast cancer

  1993cites this paper
• Axillary lymph node metastasis in breast cancer: prognostic indicator or lead-time bias?

  1993cites this paper
• Estrogen receptor determination and long term survival of patients with carcinoma of the breast.

  1991cites this paper
• [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].

  1991cites this paper
• The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors.

  1990cites this paper
• Is Tissue Polypeptide Antigen Still a Useful Tumor Marker in Breast Carcinoma? Comparison with Ca15.3 and Mca

  1990cites this paper
• Tamoxifen metabolism: pharmacokinetic and in vitro study.

  1989cites this paper
• Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.

  1989cites this paper
• Oestrogen receptors and prognosis in breast cancer

  1989cites this paper
• Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.

  1988cites this paper
• Comment on prognosis in node negative breast cancer

  1987cites this paper